Weaver Consulting Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $388K | Buy |
498
+3
| +0.6% | +$2.34K | 0.11% | 151 |
|
|
2025
Q1 | $409K | Buy |
495
+3
| +0.6% | +$2.48K | 0.12% | 139 |
|
|
2024
Q4 | $380K | Sell |
492
-143
| -23% | -$110K | 0.12% | 137 |
|
|
2024
Q3 | $563K | Buy |
635
+44
| +7% | +$39K | 0.18% | 101 |
|
|
2024
Q2 | $535K | Sell |
591
-20
| -3% | -$18.1K | 0.19% | 98 |
|
|
2024
Q1 | $475K | Buy |
611
+5
| +0.8% | +$3.89K | 0.18% | 106 |
|
|
2023
Q4 | $353K | Buy |
606
+10
| +2% | +$5.83K | 0.14% | 127 |
|
|
2023
Q3 | $320K | Sell |
596
-130
| -18% | -$69.8K | 0.14% | 130 |
|
|
2023
Q2 | $340K | Buy |
726
+53
| +8% | +$24.9K | 0.15% | 121 |
|
|
2023
Q1 | $231K | Buy |
673
+4
| +0.6% | +$1.37K | 0.11% | 157 |
|
|
2022
Q4 | $245K | Hold |
669
| – | – | 0.12% | 148 |
|
|
2022
Q3 | $216K | Buy |
669
+5
| +0.8% | +$1.61K | 0.12% | 152 |
|
|
2022
Q2 | $215K | Sell |
664
-75
| -10% | -$24.3K | 0.12% | 153 |
|
|
2022
Q1 | $212K | Hold |
739
| – | – | 0.1% | 164 |
|
|
2021
Q4 | $204K | Buy |
+739
| New | +$204K | 0.1% | 163 |
|
|
2020
Q4 | – | Sell |
-640
| Closed | -$95K | – | 559 |
|
|
2020
Q3 | $95K | Hold |
640
| – | – | 0.05% | 195 |
|
|
2020
Q2 | $105K | Buy |
640
+9
| +1% | +$1.48K | 0.06% | 183 |
|
|
2020
Q1 | $88K | Hold |
631
| – | – | 0.06% | 176 |
|
|
2019
Q4 | $71K | Hold |
631
| – | – | 0.04% | 199 |
|
|
2019
Q3 | $69K | Hold |
631
| – | – | 0.04% | 199 |
|
|
2019
Q2 | $70K | Hold |
631
| – | – | 0.04% | 189 |
|
|
2019
Q1 | $72K | Buy |
+631
| New | +$72K | 0.02% | 399 |
|